← ANALYST RATINGS · TIPRANKS

Progyny (PGNY): analyst forecast and price target

$26.86 −2.17% close 16.10.26 · market cap $2.1B · Healthcare · Medical - Healthcare Plans IWM 0.07%
Price targets and ratings of

Analyst consensus

Moderate Buy

4 Buy2 Hold0 Sell

Ratings of 6 analysts in the last 3 months · top analysts only

12-month forecast

$32.33+20.4% upside

Based on 6 price targets given in the last 3 months, the average target is $32.33, the highest $37.00, the lowest $30.00. The average is +20.4% from the last price of $26.86.

$20.00$30.00Jan 26AprJulOctJan 27AprJulOctHigh$37.00Average$32.33Low$30.00
Highest target $37.00 Average target $32.33 Lowest target $30.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Stan Berenshteyn★★★★★★★★★★#11485 · hits 50% · avg −5.0% Wells Fargo $37.00 Buy +37.8% Assigned 16.10.26on TipRanks 07:09 −1.1%
Michael Cherny★★★★★★★★★★#2074 · hits 57% · avg +5.7% Leerink Partners $37.00 Buy +37.8% Reiterated 15.10.26on TipRanks 07:55 −1.7%next day −1.1%
Peter Warendorf★★★★★★★★★★#2259 · hits 83% · avg +21.9% Barclays $30.00 Hold +11.7% Reiterated 15.10.26on TipRanks 05:07 −1.7%next day −1.1%
Richard Close★★★★★★★★★★#1081 · hits 49% · avg +10.0% Canaccord Genuity $35.00 Buy +30.3% Reiterated 07.10.26on TipRanks Oct 8 07:15 +6.6%next day +1.4% · 5 days +2.0%
Michael Cherny★★★★★★★★★★#2074 · hits 57% · avg +5.7% Leerink Partners — Buy — Reiterated 07.10.26on TipRanks 11:55 +6.6%next day +1.4% · 5 days +2.0%
Constantine Davides★★★★★★★★★★#12158 · hits 36% · avg −12.7% Citizens JMP $31.00 → $33.00+6.5% Buy +22.9% Reiterated 08.09.26on TipRanks 05:55 +5.2%next day +0.4% · 5 days +3.4%
Lisa Gill★★★★★★★★★★#1237 · hits 58% · avg +9.0% J.P. Morgan $27.00 → $30.00+11.1% Hold +11.7% Reiterated 21.08.26on TipRanks 07:40 −1.6%next day −0.5% · 5 days +0.9%
Stan Berenshteyn★★★★★★★★★★#11485 · hits 50% · avg −5.0% Wells Fargo $37.00 Buy +37.8% Initiated 20.08.26on TipRanks 05:11 +2.5%next day −1.6% · 5 days −1.5%
Jailendra Singh★★★★★★★★★★#12131 · hits 43% · avg −6.4% Truist Financial $33.00 → $36.00+9.1% Buy +34.0% Reiterated 13.08.26on TipRanks 07:50 +1.2%next day +1.7% · 5 days +2.2%
Peter Warendorf★★★★★★★★★★#2259 · hits 83% · avg +21.9% Barclays $34.00 → $30.00−11.8% Hold +11.7% Reiterated 12.08.26on TipRanks 05:15 −4.6%next day +1.2% · 5 days +0.9%
Richard Close★★★★★★★★★★#1081 · hits 49% · avg +10.0% Canaccord Genuity $35.00 Buy +30.3% Reiterated 11.08.26on TipRanks Aug 12 07:20 −4.3%next day −4.6% · 5 days −2.8%
Allen Lutz★★★★★★★★★★#598 · hits 67% · avg +12.3% Bank of America Securities $31.00 Buy +15.4% Reiterated 07.08.26on TipRanks 08:25 −7.6%next day −0.9% · 5 days −6.9%
Sarah James★★★★★★★★★★#2265 · hits 55% · avg +5.7% Cantor Fitzgerald $31.00 Buy +15.4% Reiterated 06.08.26on TipRanks Aug 7 09:06 −3.5%next day −7.6% · 5 days −15.5%
David Larsen★★★★★★★★★★#12072 · hits 35% · avg −4.7% BTIG $30.00 → $40.00+33.3% Buy +48.9% Reiterated 24.07.26on TipRanks 07:31 +1.5%next day +1.3% · 5 days −1.3%
Michael Cherny★★★★★★★★★★#2074 · hits 57% · avg +5.7% Leerink Partners $30.00 → $38.00+26.7% Buy +41.5% Reiterated 22.07.26on TipRanks Jul 24 05:14 −2.6%next day −0.8% · 5 days +2.5%
Scott Schoenhaus★★★★★★★★★★#12104 · hits 35% · avg −9.7% KeyBanc $30.00 → $35.00+16.7% Buy +30.3% Reiterated 13.07.26on TipRanks 05:15 +5.1%next day +0.8% · 5 days +0.3%
Unknown Analyst Goldman Sachs $30.00 Buy +11.7% Upgrade 19.05.26on TipRanks May 26 21:02 +3.0%next day +3.2% · 5 days +1.3%
Unknown Analyst Jefferies $33.00 Buy +22.9% Reiterated 19.11.25on TipRanks 10:10 −2.1%next day −0.7% · 5 days +2.5%

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering Progyny

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Sarah James★★★★★★★★★★Cantor Fitzgerald · #2265
Hits 55%182 of 330 Average return +5.7%
1 year Allen Lutz★★★★★★★★★★Bank of America Securities · #598
Hits 67%216 of 324 Average return +12.3%
2 years Allen Lutz★★★★★★★★★★Bank of America Securities · #598
Hits 67%216 of 324 Average return +12.3%

Most profitable

3 months Sarah James★★★★★★★★★★Cantor Fitzgerald · #2265
Hits 55%182 of 330 Average return +5.7%
1 year Sarah James★★★★★★★★★★Cantor Fitzgerald · #2265
Hits 55%182 of 330 Average return +5.7%
2 years Sarah James★★★★★★★★★★Cantor Fitzgerald · #2265
Hits 55%182 of 330 Average return +5.7%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $34.18 at a price of $25.19 (+35.7%); now: $34.00 at $26.86 (+26.6%).

$25.00$30.00Sep 15Oct 1Oct 15Top analysts$32.33Average target$34.00Price$26.86

PriceAverage targetTop analysts’ target

Recommendation trend · top analysts

051063Oct 25133Nov143Dec142Jan 26242Feb244Mar224Apr63May61Jun83Jul75Aug65Sep74Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy000000
Buy668767
Hold313554
Sell000000

Earnings and sales forecast

Next report: 29.10.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $0.31 (from $0.29 to $0.35). Last quarter: $0.34.

Sales

Next quarter’s sales estimate — $341M (from $336M to $345M). Last quarter: $351M.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Progyny
  • CEO: Pete Anevski
  • Employees: 846
  • 1359 Broadway, New York City, NY, 10018, US
  • www.progyny.com

Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.

Data from the stock’s TipRanks forecast page, read 6 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗